Hudson River Biotechnology
- Company typePrivate
- Founded2021
- HeadquartersWageningen, Netherlands
- Headcount11–50
- GTM typeB2B
- OfferingServices
Hudson River Biotechnology firmographics
Firmographics- Name
- Hudson River Biotechnology
- Legal name
- Hudson River Biotechnology
- Website
- https://hudsonriverbiotechnology.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Hudson River Biotechnology industry classification
Industry- Product category
- Plant Biotechnology / Agricultural Genome Editing Services
- akta.pro primary industry
- Biotechnology & Gene-Edited Trait Development (AFAGAIAG)
Keywords
Where Hudson River Biotechnology is headquartered
LocationHeadquarters
- HQ city
- Wageningen
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Hudson River Biotechnology business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- CRISPR Genome Editing Services: The company provides CRISPR-based genome editing services to agricultural producers, enabling crop resilience and yield improvement through their proprietary BioMaas platform. Revenue is likely generated through service contracts and technology licensing arrangements with biotech and agricultural companies.
- Agrochemical Development: Hudson River Biotechnology is expanding into agrochemicals using nanotech delivery platforms, which may represent an additional revenue stream through product sales or licensing.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Hudson River Biotechnology product offering
Product offeringCore offering
Hudson River Biotechnology provides a DNA-free CRISPR-based genome editing service for crop plants through its proprietary BioMaas platform. The platform uses protoplast-based delivery to edit plant genomes without introducing foreign DNA, supporting multi-trait targeting and scalable automation. Products are delivered to crop producers and agricultural biotechnology partners in a 12-18 month timeline.
Product overview
Hudson River Biotechnology offers a single unified platform called BioMaas, which provides DNA-free CRISPR-based genome editing services for crops. The platform enables producers to boost crop resilience and yield through protoplast-based gene editing. Key features include DNA-free editing (free of foreign DNA, crop and CRISPR-enzyme agnostic), multi-trait targeting (optimizing multiple embedded and desired traits in one crop), scalability through automation, and efficiency with 12-18 month product completion timelines.
Differentiator
Problem solved
Functional benefit
Products and services
- BioMaas Platform
Quantifiable outcome
- Products completed in 12-18 months once BioMaas is implemented
Companies that use Hudson River Biotechnology
Customer profileSegments2 records
Ideal customer profiles1 record
Hudson River Biotechnology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Hudson River Biotechnology partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Hudson River Biotechnology competitors and assessment
Company assessmentDirect peers
- Pairwise: Pairwise is a US-based agricultural gene-editing company using CRISPR/Cas tools to develop improved varieties of fruits, vegetables, and row crops. It directly competes with HRB in delivering CRISPR-enabled trait improvements to seed and produce companies via a B2B partnering/licensing model.
- Tropic Biosciences: Tropic Biosciences is a UK-based agricultural biotech using CRISPR-based gene editing for tropical crops (banana, coffee) and a GEiGS technology platform. It is closely comparable to HRB in deploying novel CRISPR methodologies to commercial crop improvement via partnerships.
- Cibus: Cibus is a US-based agricultural technology company that develops gene-edited traits in crops using its RTDS (Rapid Trait Development System) platform. It is a direct peer to HRB in commercializing non-transgenic gene edits for major row crops via licensing to seed companies.
- Inari Agriculture: Inari is a US-based seed-design company that combines AI with multiplex gene editing to develop high-performance seeds. It is comparable to HRB in using next-generation breeding and editing tools to deliver multi-trait seed products to row-crop partners.
- Benson Hill: Benson Hill is a US-based crop-improvement company combining genomics, AI, and breeding to develop higher-yielding, more nutritious crops. It overlaps with HRB in serving crop producers with technology-enabled seed solutions, though with a heavier food/ingredient commercial angle.
Broad incumbents
- KeyGene: KeyGene is a Dutch plant-genomics company based in Wageningen (the same cluster as HRB) that provides molecular breeding, trait discovery, and genomic services to global seed companies. It is a comparable ag-biotech services peer with overlapping customer base and technology scope.
- Bayer Crop Science: Bayer Crop Science operates one of the largest in-house agricultural biotech pipelines, including CRISPR-based trait development, as part of its broader seeds-and-traits portfolio. It competes with HRB by integrating similar technologies into a much larger commercial platform.
- Corteva Agriscience: Corteva is a major agricultural input company with significant internal gene-editing capabilities (including its own CRISPR program with Broad Institute license). It is a broad incumbent that competes for the same seed-company customer wallet as HRB, but at vastly larger scale.
- Syngenta Group: Syngenta is a global agrochemical and seed company with active gene-editing and trait-discovery programs. It is a broad incumbent competitor that could partner with or compete against HRB depending on its internal capability roadmap.
Emerging players
- Caribou Biosciences: Caribou Biosciences is a CRISPR platform company with applications spanning human therapeutics and agricultural biology. It is an emerging player with partial overlap — its underlying CRISPR technology platforms are conceptually adjacent to HRB's BioMaas, though its primary commercial focus is biomedical.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Hudson River Biotechnology social profiles
Digital presenceHudson River Biotechnology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hudson River Biotechnology leadership team
Management profileNumber of profiles
Profiles2 records
Hudson River Biotechnology funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hudson River Biotechnology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hudson River Biotechnology
What does Hudson River Biotechnology do?
Hudson River Biotechnology provides a DNA-free CRISPR-based genome editing service for crop plants through its proprietary BioMaas platform. The platform uses protoplast-based delivery to edit plant genomes without introducing foreign DNA, supporting multi-trait targeting and scalable automation. Products are delivered to crop producers and agricultural biotechnology partners in a 12-18 month timeline.
Is Hudson River Biotechnology a public or private company?
Hudson River Biotechnology is a private company. It is classified as venture growth investor backed and is currently operating.
When was Hudson River Biotechnology founded?
Hudson River Biotechnology was founded in 2021. It employs 11 to 50 people.
Where is Hudson River Biotechnology based?
Hudson River Biotechnology is headquartered in Wageningen, Netherlands, in the Europe region.
How does Hudson River Biotechnology make money?
Two revenue lines are on record. CRISPR Genome Editing Services are the primary driver. The others are agrochemical Development.
Who are Hudson River Biotechnology's main competitors?
Direct peers on record are Pairwise, Tropic Biosciences, Cibus, Inari Agriculture and Benson Hill. Broad incumbents are KeyGene, Bayer Crop Science, Corteva Agriscience and Syngenta Group. Caribou Biosciences is listed as an emerging player.
Does Hudson River Biotechnology have an API?
No public API is recorded for Hudson River Biotechnology.
What industry is Hudson River Biotechnology in?
Hudson River Biotechnology's product category is Plant Biotechnology / Agricultural Genome Editing Services. Its primary akta.pro industry code is AFAGAIAG, Biotechnology & Gene-Edited Trait Development.